Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Practical, Pilot, Randomized, Controlled Trial of Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium

NCT04513314 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT04513314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Practical, Pilot, Randomized, Controlled Trial of Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium
Lead sponsor
University of Miami
Phase
Phase 4
Overall status
Withdrawn
Start date
March 28, 2023
Completion date
March 28, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hyperactive delirium, pneumonia, viral